E08.3293 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, bilateral

Name of the Condition

• Diabetes mellitus due to underlying condition with mild nonprolative diabetic retinopathy without macular edema, bilateral

Summary

This condition refers to diabetes mellitus that develops secondary to another underlying health issue, accompanied by mild nonproliferative diabetic retinopathy without macular edema, affecting both eyes. It involves damage to the retina due to prolonged high blood sugar levels, with early-stage changes that do not include abnormal blood vessel growth. The retinopathy is classified as mild, indicating minimal microaneurysms or dot-blot hemorrhages without significant vision-threatening features, and macular edema is absent in both eyes.

Causes

Diabetes mellitus due to an underlying condition occurs when another health issue impairs insulin production or function, leading to elevated blood glucose levels. These underlying conditions may include pancreatic disease, hormonal disorders, or certain genetic syndromes. The resulting hyperglycemia damages blood vessels and tissues in the retina over time, causing nonproliferative changes without macular edema in both eyes.

Risk Factors

• Having an underlying condition that affects insulin or glucose metabolism.
• Long-standing uncontrolled diabetes.
• High blood pressure and high cholesterol.
• Smoking and obesity.
• Advanced age.

Symptoms

• Blurred or distorted vision.
• Floaters or dark spots in the field of vision.
• Difficulty seeing at night.
• Slight changes in color perception.

Diagnosis

Diagnosis involves a comprehensive eye exam, including a dilated retinal examination and optical coherence tomography (OCT) to assess retinal thickness and detect macular edema. Blood tests to evaluate blood glucose levels and identify underlying conditions contributing to diabetes are also performed. Imaging studies may be used to confirm retinal changes and rule out other eye disorders.

Treatment Options

Treatment focuses on managing blood sugar levels through medication, diet, and exercise to slow retinopathy progression. Regular eye exams are essential to monitor for changes. In some cases, laser therapy or anti-VEGF injections may be considered if retinopathy advances, though these are not typically needed for mild nonproliferative cases without macular edema.

Prognosis and Follow-Up

With proper blood sugar control and regular monitoring, the prognosis for mild nonproliferative diabetic retinopathy without macular edema is generally favorable. Follow-up appointments with an ophthalmologist are recommended to track retinal changes and adjust treatment as needed. Early intervention can prevent progression to more severe stages.

Complications

If left unmanaged, mild nonproliferative diabetic retinopathy may progress to moderate or severe nonproliferative retinopathy, increasing the risk of macular edema, proliferative retinopathy, or vision loss. Other complications include cataracts and glaucoma, which are more common in individuals with diabetes.

Lifestyle & Prevention

• Maintain stable blood sugar levels through consistent medication and lifestyle adjustments.
• Adopt a balanced diet low in refined sugars and high in fiber.
• Engage in regular physical activity to improve insulin sensitivity.
• Avoid smoking and limit alcohol consumption.
• Manage blood pressure and cholesterol through diet, exercise, or medication.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, increased floaters, or eye pain. Regular eye exams are crucial for early detection of retinopathy progression, even if symptoms are mild or absent.

Tips for Medical Coders

Document the bilateral nature of the retinopathy and confirm the absence of macular edema. Ensure the underlying condition causing diabetes is clearly identified and linked to the retinopathy. Use this code only when both eyes are affected by mild nonproliferative changes without macular edema.